Wealth Enhancement Trust Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$386K Buy
13,523
+4,093
+43% +$109K 0.04% 237
2026
Q2
$227K Buy
9,430
+1,033
+12% +$27K 0.03% 275
2026
Q1
$236K Sell
8,397
-2,584
-24% -$68.8K 0.03% 266
2025
Q4
$273K Buy
+10,981
New +$277K 0.03% 237

Other funds holding PFE

Wealth Enhancement Trust Services's PFE Position: Q3 2026 in Review

Wealth Enhancement Trust Services increased its Pfizer (PFE) stake by 43% in Q3 2026, buying an estimated $109K and bringing the position to 13,523 shares worth $386K. The position accounts for 0.04% of the portfolio, ranked #237.

Wealth Enhancement Trust Services first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Wealth Enhancement Trust Services held 13,523 shares of Pfizer worth $386K as of Q3 2026.
  • Wealth Enhancement Trust Services bought 4,093 Pfizer shares in Q3 2026, an estimated $109K.
  • Pfizer made up 0.04% of Wealth Enhancement Trust Services's portfolio in Q3 2026, its #237 holding.
  • Wealth Enhancement Trust Services first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.